Canthera Therapeutics Inc.;Massachusetts General Hospital Corporation
发明人:
Anna Mandinova,Michael Andrew Foley,Peter Elliot,Robert Gould,Sam Lee
申请号：
BR112012004701
公开号：
BR112012004701A2
申请日:
2010.09.02
申请国别(地区):
BR
年份:
2018
代理人:
摘要：
The invention relates to compounds and composition for the treatment and prevention of cancer. The invention also covers all diseases that may be treated by selective modulation of levels of reactive oxygen species in diseased cells versus normal cells. Methods for the preparation and administration of such compositions are also disclosed.
